Hallucinogen Eases Depression in Cancer Patients, Studies Find
Two studies used psilocybin to see if the drug could reduce depression and anxiety in cancer patients. The results were striking.
Highlights
-
Photo
CreditIsaac Brekken for The New York Times -
Photo 
CreditGetty Images Phys Ed
Should a Simple Fitness Check Be Part of Your Checkup?
Experts think your fitness level should be monitored just as your pulse or blood pressure is.
-
-
Photo 
CreditPatrick T. Fallon for The New York Times Insomniacs Are Helped by Online Therapy, Study Finds
The report suggests that many garden-variety insomniacs could benefit from cognitive behavior therapy without ever having to talk to a therapist.
-
Photo 
CreditSam Hodgson for The New York Times U.S. Will Ban Smoking in Public Housing Nationwide
Officials said the rule, which bars tobacco use in apartments, common areas and offices, will take effect in early 2017. It will cover the homes of more than 400,000 New York City residents.
-
-
Photo 
CreditIvan Kashinsky for The New York Times Why Gunshot Victims Have Reason to Like the Affordable Care Act
The expansion of state Medicaid programs under the health care law has brought coverage, and necessary treatment, to previously uninsured shooting victims.
-
Photo 
CreditTravis Dove for The New York Times F.D.A. Agrees to New Trials for Ecstasy as Relief for PTSD Patients
The Food and Drug Administration has approved large-scale clinical trials to study MDMA, the illegal party drug better known as Ecstasy, as treatment for PTSD patients.
-
Photo 
CreditDrew Angerer for The New York Times Tom Price, H.H.S. Nominee, Drafted Remake of Health Law
Mr. Price’s bill, the Empowering Patients First Act, would weaken many consumer protections in the Affordable Care Act, President Obama’s signature domestic achievement.
-
Personal Health
Photo 
CreditPaul Rogers What Not to Say to a Cancer Patient
Shopping for groceries or walking the dog can be more helpful than offering false optimism.
-
Photo 
Credit Stroke Rates Rising in Younger People
Stroke rates have been declining in older people over the past 20 years — but have sharply increased in those under 55.
Cell Wars: The Science of Immunotherapy
More in Cell Wars: The Science of Immunotherapy »-
Photo 
CreditJohnson et al., New England Journal of Medicine, 2016 Lifesaving Cancer Drugs May in Rare Cases Threaten the Heart
Drugs called checkpoint inhibitors that harness the immune system to fight cancer can, in rare cases, cause heart damage. Patients may need extra heart tests during treatment.
-
Photo 
CreditNick Cote for The New York Times Immune System and Spirit Kept Cancer at Bay for a Year
Jason Greenstein fought off Hodgkin’s lymphoma with immunotherapy, but prolonged exposure to chemotherapy and radiation weakened his body. He died Aug. 10.
-
Photo 
CreditJesse Dittmar for The New York Times Setting the Body’s ‘Serial Killers’ Loose on Cancer
After a long, intense pursuit, researchers are close to bringing to market a daring new treatment: cell therapy that turbocharges the immune system to fight cancer.
-
Photo 
CreditNick Cote for The New York Times Immunotherapy Offers Hope to a Cancer Patient, but No Certainty
Drawing on his immune system to fight Hodgkin’s lymphoma, my friend saw a stunning improvement. Then came the relapses.
-
Photo 
CreditSam Hodgson for The New York Times Harnessing the Immune System to Fight Cancer
New drugs and methods of altering a patient’s own immune cells are helping some cancer patients — but not all — even when standard treatments fail.
